AKAN
Akanda Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$1.00
−7.43%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$1.03
From 52W high−98.25%
Volume94112.00
Market cap$2.64M
P/E (TTM)—
P/S (TTM)4.0x
Div yield—
Key dataNov 4, 2026
Open
$1.03
From 52W high
−98.25%
Volume
94112.00
Market cap
$2.64M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.4x
P/E (TTM)
—
RSI (14)
25.4
MomentumView details →
1D Return
−7.43%
YTD Return
−88.74%
SummaryUpdated Jun 1, 2026
Akanda Corp. (NASDAQ:AKAN) is a cannabis cultivation, manufacturing, and distribution company founded in 2021 and headquartered in New Romney, United Kingdom. The company went public in March 2022 and operates primarily in the United Kingdom and Lesotho, focusing on the production and distribution of medical cannabis and wellness products. Since its inception, Akanda has been working to establish itself in the emerging global medical cannabis market, though it has faced significant operational and financial challenges in its early years as a public company.
Similar companies
Latest newsMore news →
Akanda Corp.'s subsidiary First Towers & Fiber Corp. delivered an operational and expansion update on Friday.82d agoAkanda Corp.'s subsidiary First Towers & Fiber Corp. completed a 200 km fiber network in Mexico, increasing recurring revenue.83d agoAkanda Corp. received a Nasdaq notice for non-compliance with the minimum stockholders' equity requirement.139d ago